SME Times is powered by   
Search News
Just in:   • Greatest champion of US-India partnership: US, other nations mourn passing of Dr Singh  • Global leaders pay tribute to former PM Dr. Manmohan Singh  • PM Modi condoles demise of Dr. Manmohan Singh  • Bird flu tightens grip on California as human cases rise  • Dr Singh presented milestone budget of 1991 which liberalised Indian economy: FM Sitharaman 
Last updated: 27 Sep, 2014  

Skanray Technologies Acquires Italian X-ray Firm CEI-Italy

PR Newswire | 22 Jul, 2014
Mysore-based Skanray Technologies Acquires Italian X-ray Firm CEI-Italy

MYSORE, India: Skanray Technologies, a medical equipment manufacturing company, announced its expansion into Europe with the acquisition of Bologna based CEI-Italy (Compagnia Elettronica Italiana), which is an x-ray tube manufacturer.  The acquisition follows Skanray setting up its own R&D unit in Europe in late 2013.  The CEI acquisition makes Skanray the first ever Indian company to be now recognised as a global medical devices manufacturer.

The acquisition of CEI is strategic in nature as now Skanray can develop core combined technology in the medtech space. The acquisition includes the manufacturing unit, the technology and its people.  Skanray's R&D division in India and Italy will work together to develop and manufacture world class medical equipments.

Skanray's Europe R&D centre and manufacturing unit at Bologna, Italy will manufacture medical devices for the EU and North America OEM market. It will also work on advanced technologies in the imaging and monitoring product space - mobile DR systems, portable ultrasound, telemedicine monitors. The Europe R&D centre has a team of 20 scientists (India and global) to collaborate on product design and development.

"Establishing our R&D and manufacturing unit in international markets is a huge milestone for us and positions Skanray amongst the top global medtech manufacturers," said Vishwaprasad Alva, Managing Director and Founder, Skanray Technologies. He further added, "Skanray expects the next phase of growth in medical technologies to be driven by the demand for primary healthcare solutions. Both the Italian manufacturing units will complement the India manufacturing in building world class healthcare products."

About Skanray Technologies 

Skanray Technologies, founded in 2007, commenced commercial production in 2011 and has today grown to a team of 500 medtech professionals, with operations in India, Europe and Latin America. Skanray is a medical equipment manufacturer that enables intelligent healthcare delivery in radiology, critical care, patient monitoring, primary healthcare solutions and telemedicine. The company has grown rapidly within a short time since its inception and has acquired L&T Medical Equipments (2012) and Pricol's medtech business in 2013. It has its own large installed base in India and is also an OEM partner to some of the world's best medical equipment brands. The company holds a technology patent in reducing the leakage radiation to one of the lowest in the world - typically to less than 0.1mR (milli Rongent) while the permitted limit is 50 mR.  The company follows highest standard of corporate governance partnering with Deloitte and Sells, PwC, G &T, DSK legal and has  ISO 13485, UL, CE and US FDA certified products in its range. Skanray has been funded by Ascent Capital Private Equity Firm in 2013. 

For more information, visit http://www.skanray.com/

Media Contact: Savya Shankar, savya@galvanisepr.com, +91-8050-224-658, Galvanise PR


 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Will the new MSME credit assessment model simplify financing?
 Yes
 No
 Can't say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter